Title : Prolyl hydroxylase inhibitor desidustat improves anemia in erythropoietin hyporesponsive state.

Pub. Date : 2022

PMID : 35570856






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Many anemic chronic kidney disease (CKD) patients are refractory to erythropoietin (EPO) effects due to inflammation, deranged iron utilization, and generation of EPO antibodies. Iron erythropoietin Homo sapiens
2 Many anemic chronic kidney disease (CKD) patients are refractory to erythropoietin (EPO) effects due to inflammation, deranged iron utilization, and generation of EPO antibodies. Iron erythropoietin Homo sapiens